<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Vertex Pharmaceuticals Incorporated

    Vertex Pharmaceuticals Incorporated

    Vertex is a global biotechnology company that invests in scientific innovation to ...

    Vertex is a global biotechnology company that i...

    Filing Type:    PU
    Ansell Ltd.

    Ansell Ltd.

    Ansell Limited provides health and safety protection solutions. The Company has op...

    Ansell Limited provides health and safety prote...

    Filing Type:    PR
    Anixa Biosciences, Inc.

    Anixa Biosciences, Inc.

    Anixa is focused on harnessing the body’s immune system in the fight against can...

    Anixa is focused on harnessing the body’s imm...

    Filing Type:    PU
    SmartRX Systems

    SmartRX Systems

    Smart Rx Systems has created a medication management system that dispenses medicat...

    Smart Rx Systems has created a medication manag...

    Fundraising Status:    EC
    Filing Type:    RA
    resTORbio, Inc.

    resTORbio, Inc.

    resTORbio, Inc. is a clinical-stage biopharmaceutical company developing innovativ...

    resTORbio, Inc. is a clinical-stage biopharmace...

    Filing Type:    PU
    Menlo Therapeutics Inc.

    Menlo Therapeutics Inc.

    We are a late stage biopharmaceutical company focused on the development and comme...

    We are a late stage biopharmaceutical company f...

    Filing Type:    PU
    Diffusion Pharmaceuticals Inc.

    Diffusion Pharmaceuticals Inc.

    Diffusion Pharmaceuticals is a clinical stage company focused on improving the eff...

    Diffusion Pharmaceuticals is a clinical stage c...

    Filing Type:    PU
    NeoGenomics, Inc.

    NeoGenomics, Inc.

    NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory and phar...

    NeoGenomics, Inc. is a high-complexity CLIA-cer...

    Filing Type:    PU
    Vivos Inc

    Vivos Inc

    The Company is a radiation oncology medical device company engaged in the developm...

    The Company is a radiation oncology medical dev...

    Fundraising Status:    EC
    Filing Type:    RA
    ©2026 National Investor Network. All Rights Reserved.